BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35634790)

  • 41. Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer.
    McDermott M; Hughes M; Rath T; Johnson JT; Heron DE; Kubicek GJ; Kim SW; Ferris RL; Duvvuri U; Ohr JP; Branstetter BF
    AJNR Am J Neuroradiol; 2013 Aug; 34(8):1632-6. PubMed ID: 23639557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lockdown low vision assessment: an audit of 500 telephone-based modified low vision consultations.
    Patel A; Fothergill AS; Barnard KEC; Dunbar H; Crossland MD
    Ophthalmic Physiol Opt; 2021 Mar; 41(2):295-300. PubMed ID: 33529405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emergency presentations of head and neck cancer: Our experience in the wake of the COVID-19 pandemic.
    Wilkie MD; Gaskell P; Hall B; Jones TM; Kinshuck AJ
    Clin Otolaryngol; 2021 Nov; 46(6):1237-1241. PubMed ID: 34097807
    [No Abstract]   [Full Text] [Related]  

  • 44. Telemedicine in paediatric otorhinolaryngology: Lessons learnt from remote encounters during the Covid19 pandemic and implications for future practice.
    Sharma S; Daniel M
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110411. PubMed ID: 33022557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract.
    Perlow A; Bui C; Shreve P; Sundgren PC; Teknos TN; Mukherji SK
    J Comput Assist Tomogr; 2004; 28(5):704-9. PubMed ID: 15480048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
    Abgral R; Querellou S; Potard G; Le Roux PY; Le Duc-Pennec A; Marianovski R; Pradier O; Bizais Y; Kraeber-Bodéré F; Salaun PY
    J Nucl Med; 2009 Jan; 50(1):24-9. PubMed ID: 19091901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Telephone triage for 2-week-wait cancer clinics: a viable alternative to face-to-face clinics?
    Garrard A; Bashyam A; Pitkin L
    Ann R Coll Surg Engl; 2023 Apr; 105(4):348-351. PubMed ID: 36259330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A retrospective cohort study of telephone versus face-to-face clinics for the management of new otology referrals.
    Metcalfe C; Gaskell P; McLelland T; Patel S; Muzaffar J; Dalton L; Coulson C
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1677-1682. PubMed ID: 36109380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic.
    Cavalieri S; Colombo E; Bottiglieri A; Massa G; Platini F; Ottini A; Filippini DM; Zattarin E; Bergamini C; Resteghini C; Alfieri S; Di Martino V; Tiraferri V; Locati LD; Licitra L
    Tumori; 2022 Jun; 108(3):240-249. PubMed ID: 33849307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of head and neck cancer management from two cancer centres in Southern and Northern Europe during the first wave of COVID-19.
    Tagliabue M; Russell B; Moss C; De Berardinis R; Chu F; Jeannon JP; Pietrobon G; Haire A; Grosso E; Wylie H; Zorzi S; Proh M; Brunet-Garcia A; Cattaneo A; Oakley R; De Benedetto L; Arora A; Riccio S; Fry A; Bruschini R; Townley W; Giugliano G; Orfaniotis G; Madini M; Dolly S; Borghi E; Aprile D; Zurlo V; Bibiano D; Mastrilli F; Chiocca S; Van Hemelrijck M; Gandini S; Simo R; Ansarin M
    Tumori; 2022 Jun; 108(3):230-239. PubMed ID: 33845703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Routine follow-up in patients treated of head and neck cancer].
    Wierzbicka M; Waśniewska E; Jackowska J; Leszczyńska M; Szyfter W
    Otolaryngol Pol; 2012; 66(2):138-47. PubMed ID: 22500505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of COVID-19 pandemic on hospital visit of head and neck cancer patients.
    Hamaguchi K; Shinohara S; Michida T; Yasumoto M; Hamamoto A; Yamamoto T; Ueda K; Nakamura E
    Auris Nasus Larynx; 2023 Dec; 50(6):948-951. PubMed ID: 37137795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Symptom burden among head and neck cancer patients in the first year after diagnosis: Association with primary treatment modality.
    Allen-Ayodabo CO; Eskander A; Davis LE; Zhao H; Mahar AL; Karam I; Singh S; Gupta V; Bubis LD; Moody L; Barbera L; Coburn NG
    Oral Oncol; 2019 Dec; 99():104434. PubMed ID: 31630058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302).
    Oswald LB; Lee JW; Argiris A; Webster KA; Forastiere AA; Cella D
    Cancer Med; 2020 Dec; 9(23):8884-8894. PubMed ID: 33040481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Missed cancer in the Danish head and neck cancer fast-track program: results from a tertiary cancer center.
    Schmidt IG; Korsholm M; Johansen J; Sørensen JA; Godballe C; Bjørndal K
    Acta Oncol; 2023 Aug; 62(8):836-841. PubMed ID: 37493617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-treatment surveillance imaging in head and neck cancer: a systematic review.
    Van Hoe S; Hermans R
    Insights Imaging; 2024 Feb; 15(1):32. PubMed ID: 38315325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Symptoms and Clinical Findings With Anticipated Outcomes in Patients With Recurrent Head and Neck Cancer.
    Pipkorn P; Licata J; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):738-745. PubMed ID: 30003215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of coronavirus disease 2019 on the head and neck cancer pathway in the West of Scotland.
    Drake I; Rogers A; Stewart M; Montgomery J
    J Laryngol Otol; 2022 Jun; 136(6):535-539. PubMed ID: 35225177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of the COVID-19 pandemic on head and neck cancer diagnosis: data from a single referral center, South Tyrol, northern Italy.
    Gazzini L; Fazio E; Dallari V; Accorona R; Abousiam M; Nebiaj A; Giorgetti G; Girolami I; Vittadello F; Magnato R; Patscheider M; Mazzoleni G; Calabrese L
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3159-3166. PubMed ID: 34739577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.